Evidence map›Paper›PMID 40450184›Full record

ArticleDigestive diseases and sciences2025

Sarcopenic Obesity and MASLD: A Dangerous Duo Driving Deadly Cardiometabolic Risk.

Theja Channapragada, Jonathan G Stine

Abstract readEditorial
PubMed Full text at PMC Publisher
In one paragraph

Article in Digestive diseases and sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Effects of GLP-1 Receptor Agonists on Muscle Mass, Strength, and Quality in MASLD: A Systematic Review.Liver international : official journal of the International Association for the Study of the Liver · 2026
    Pooled it
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Theja ChannapragadaDepartment of Medicine, Penn State Health- Milton S. Hershey Medical Center, Hershey, PA, USA.
Jonathan G StineDivision of Gastroenterology and Hepatology, Department of Medicine, Penn State Health- Milton S. Hershey Medical Center, 500 University Drive, Hershey, PA, 17033, USA. jstine@pennstatehealth.psu.edu.

Funding

Establishing the mechanism of benefit and dose of exercise required to improve liver histology in patients with nonalcoholic steatohepatitisK23DK131290 · NIDDK · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI STINE, JONATHAN G · 2022 to 2025
$801k
NIDDK NIH HHS K23 DK131290
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Metabolic dysfunction-associated steatohepatitisMetabolic dysfunction-associated steatotic liver diseaseMuscle lossMyosteatosis

Identifiers

PMID40450184
PMCPMC12536939

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.